Trading IdeasFundamentals

Pfizer Ltd

NSE: PFIZER · Pharmaceuticals · sector

₹3,687.20NSE close 2026-10-26

Key numbers

Market cap₹16,869 cr
Price₹3,687.20
52w high / low₹5,446 / ₹3,687
P/E22.9xSector median 27.9x
P/B4.0xSector median 2.9x
Book value₹918.7
Dividend yield4.45%Sector median 0.48%
ROE17.5%Sector median 11.7%
ROCE23.8%Sector median 12.3%
OPM34.7%Sector median 14.0%
Debt / equity0.00xSector median 0.16x
EV/EBITDA15.4xSector median 18.6x
Interest cover130.1x
Current ratio6.06x
Sales growth 3y+1.3%Sector median +9.6%
Profit growth 3y+5.0%Sector median +13.3%
PEG4.58x

Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹5,860.50 · low ₹3,687.20
Sep 2024Apr 2025Oct 2025Apr 2026

Quarterly results

₹ crSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue589538592603642645629653
EBITDA189146400210230170245248
OPM %32.2%27.1%67.6%34.8%35.8%26.4%38.9%37.9%
Other income4343456742384145
Net profit158128331192189142200204
EPS (₹)34.6127.8972.3441.9141.3231.0143.6844.69
Revenue YoY+9.1%+19.9%+6.3%+8.3%
Profit YoY+19.4%+11.2%-39.6%+6.6%

Standalone figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ crFY22FY23FY24FY25FY26TTM
Revenue2,6112,4252,1932,2812,5202,570
EBITDA836842643913855892
Net profit613624551768722735
EPS (₹)133.89136.38120.51167.79157.92160.70
Revenue growth-7.1%-9.6%+4.0%+10.4%+10.7%
Profit growth+1.9%-11.6%+39.2%-5.9%-9.1%
Dividend / share (₹)30.0065.0035.0035.0035.00
Compounded growth3 years5 yearsLast 12 months
Sales+1.3%+2.4%+10.7%
Net profit+5.0%+7.7%-9.1%
EPS+5.0%+7.7%–
Share price–-18.1% (2y)-29.8%

Balance sheet

₹ crFY22FY23FY24FY25FY26
Shareholders' equity–3,2073,5964,2174,203
Borrowings–2222
Cash & equivalents–1,8602,0472,8013,111
Total assets–4,0014,2294,9114,922
Fixed assets–178151172136
Capital work in progress–80820
Investments–0000
Receivables–152188193182
Inventory–418434476473
Payables–217166152216

Year-end figures from the March annual filing.

Cash flow

₹ crFY22FY23FY24FY25FY26
Cash from operations667356257660968
Cash from investing-575-3654-71-562
Cash from financing-181-346-235-205-798
Capex1565192825
Free cash flow652291238632942

Free cash flow = cash from operations − capex.

Ratios by year

₹ crFY22FY23FY24FY25FY26
ROE %–19.5%15.3%18.2%17.2%
ROCE %–26.1%21.2%24.3%23.4%
Debtor days–23313126
Inventory days–175200214195
Payable days–91776889
Cash conversion cycle (days)–107154177132
Working capital days–276365471460

Shareholding

Holder% (2026-09-30)
Promoters63.92%
FIIs1.63%
DIIs17.52%
of which Mutual funds12.83%
of which Insurance4.65%
Government0.00%
Public (non-institutions)16.92%
QuarterDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters %63.92%63.92%63.92%63.92%63.92%63.92%63.92%63.92%
Promoter group%
Pfizer East India B V39.75%
Wyeth LLC12.28%
Wyeth Holdings Corporation3.56%
Warner-lambert Company LLC2.60%
Parke, Davis & Company LLC2.09%
John Wyeth & Brother Ltd1.93%
Pharmacia Corporation1.71%
Public holders above 1%%
Nippon Life India Trustee Ltd4.11%
Quant Mutual Fund3.98%
Life Insurance Corporation of India3.25%
ICICI Prudential Fund2.22%
Atul Limited2.10%

1,04,472 shareholders. Pledged: 0.00% of promoter shares.

Peers in Pharmaceuticals

CompanyMarket capP/EP/BROEROCEOPMSales 3yDiv yield
SUNPHARMA₹4,17,478 cr34.5x5.0x15.5%18.7%28.6%+10.0%0.94%
DIVISLAB₹2,39,825 cr82.1x14.3x18.4%23.0%34.7%+10.8%0.34%
TORNTPHARM₹1,53,999 cr72.7x18.4x27.3%15.1%32.3%+13.3%0.84%
ZYDUSLIFE₹1,15,808 cr25.9x4.3x17.7%16.8%27.2%+16.4%0.95%
LAURUSLABS₹1,11,232 cr101.6x21.0x22.4%20.8%28.0%+4.1%0.08%
CIPLA₹1,09,464 cr32.5x3.2x10.3%13.2%17.7%+7.4%1.18%
DRREDDY₹1,09,460 cr33.9x2.9x9.0%10.1%15.5%+11.0%0.61%
MANKIND₹95,486 cr46.7x5.9x13.4%13.8%25.1%+17.7%0.04%
AUROPHARMA₹91,489 cr24.9x2.4x10.5%12.8%20.0%+10.6%0.26%
PFIZER₹16,869 cr22.9x4.0x17.5%23.8%34.7%+1.3%4.45%

All 185 companies in Pharmaceuticals →

Dividends & corporate actions

Ex-dateActionDetail
2026-07-17DividendDividend - Rs 75 Per Share
2025-07-09DividendDividend - Rs 35 Per Share & Special Dividend Of Rs 100 Per Share/ Special Dividend Of Rs 30
2024-08-21DividendDividend - Rs 35 Per Share
2023-08-11DividendDividend - Rs 35 Per Share/ Special Dividend - Rs 5 Per Share
2022-09-19DividendSpecial Dividend - Rs 30 Per Share
2022-08-18DividendDividend - Rs 35 Per Share
2021-08-11DividendAnnual General Meeting/Dividend - Rs 30 Per Share/Special Dividend - Rs 5 Per Share
2020-08-27DividendAnnual General Meeting/Dividend - Rs 10 Per Share
2020-05-06DividendSpecial Dividend - Rs 320 Per Share
2019-08-01DividendDividend - Rs 22.50 Per Share
2018-08-29DividendAnnual General Meeting/Dividend- Rs 20 Per Share
2017-08-22DividendDividend Rs 15/- Per Share + Special Dividend Rs 5/- Per Share
2016-06-27DividendDividend - Rs.15/- Per Share
2015-07-03DividendAnnual General Meeting And Dividend Rs.12.50 Per Share
2014-10-29OtherAnnual General Meeting
2013-12-05DividendInterim Dividend - Rs 360/- Per Share
2013-08-28DividendAnnual General Meeting / Dividend - Rs 12.50/- Per Share + Special Dividend - Rs 20/- Per Share
2012-07-24DividendAnnual General Meeting/ Dividend Rs 12.50 Per Share
2011-07-08DividendDividend-Rs.4/- Per Share
2011-01-20DividendInterim Dividend-Rs.12.50 Per Share

Documents

Links go to the original files on the exchange website.

About the company

SectorHealthcare
IndustryPharmaceuticals
Sub-industryPharmaceuticals
SymbolPFIZER
BSE code500680
ISININE182A01018
Face value₹10.0
Incorporated1950-11-21
Websitehttp://www.pfizerltd.co.in
Plants (India / abroad)1 / 0

From the company's filings (BRSR FY26).

Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.